These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37124955)

  • 1. Retraction: Dexmedetomidine and Phosphocreatine Post-treatment Provides Protection against Focal Cerebral Ischemia-reperfusion Injury in Rats.
    Acta Histochem Cytochem; 2023 Apr; 56(2):39. PubMed ID: 37124955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine and Phosphocreatine Post-treatment Provides Protection against Focal Cerebral Ischemia-reperfusion Injury in Rats.
    Sun X; Kang F; Shen Y; Shen Y; Li J
    Acta Histochem Cytochem; 2021 Aug; 54(4):105-113. PubMed ID: 34511649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection of Dexmedetomidine against Cerebral Ischemia-Reperfusion Injury in Rats: Involved in Inhibition of NF-κB and Inflammation Response.
    Wang L; Liu H; Zhang L; Wang G; Zhang M; Yu Y
    Biomol Ther (Seoul); 2017 Jul; 25(4):383-389. PubMed ID: 27871154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine attenuates cerebral ischemia/reperfusion injury in neonatal rats by inhibiting TLR4 signaling.
    Cheng J; Zhu P; Qin H; Li X; Yu H; Yu H; Peng X
    J Int Med Res; 2018 Jul; 46(7):2925-2932. PubMed ID: 29926753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Wnt/β-catenin pathway in the protection process by dexmedetomidine against cerebral ischemia/reperfusion injury in rats.
    Li P; Zhang Y; Liu H
    Life Sci; 2019 Nov; 236():116921. PubMed ID: 31610196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats.
    Zhu YM; Wang CC; Chen L; Qian LB; Ma LL; Yu J; Zhu MH; Wen CY; Yu LN; Yan M
    Brain Res; 2013 Feb; 1494():1-8. PubMed ID: 23219579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of JNK Signaling Pathway in Dexmedetomidine Post-Conditioning-Induced Reduction of the Inflammatory Response and Autophagy Effect of Focal Cerebral Ischemia Reperfusion Injury in Rats.
    Zhu Y; Li S; Liu J; Wen Q; Yu J; Yu L; Xie K
    Inflammation; 2019 Dec; 42(6):2181-2191. PubMed ID: 31446520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dexmedetomidine on cerebral ischemia-reperfusion rats by activating mitochondrial ATP-sensitive potassium channel.
    Yuan F; Fu H; Sun K; Wu S; Dong T
    Metab Brain Dis; 2017 Apr; 32(2):539-546. PubMed ID: 28035625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4/NF-κB pathways model of cerebral ischemia reperfusion.
    Wang SL; Duan L; Xia B; Liu Z; Wang Y; Wang GM
    Biomed Pharmacother; 2017 Sep; 93():1337-1342. PubMed ID: 28753906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of phosphocreatine on focal cerebral ischemia-reperfusion injury.
    Li T; Wang N; Zhao M
    J Biomed Biotechnol; 2012; 2012():168756. PubMed ID: 22505804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dexmedetomidine on microregional O2 balance during reperfusion after focal cerebral ischemia.
    Chi OZ; Grayson J; Barsoum S; Liu X; Dinani A; Weiss HR
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):163-70. PubMed ID: 25294058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
    Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic comparison of dexmedetomidine's and thiopental's cerebral protective effects on focal cerebral ischemia in rats.
    Çanakçı E; Akalp Özmen S; Çolak MF; Kürşad H
    Braz J Anesthesiol; 2016; 66(6):583-593. PubMed ID: 27793233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats.
    Kim SH; Jun JH; Oh JE; Shin EJ; Oh YJ; Choi YS
    PLoS One; 2018; 13(8):e0198307. PubMed ID: 30114208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats via Extracellular Signal-Regulated Kinase/Cyclic Adenosine Monophosphate Response Element Binding Protein Signaling Pathway.
    Teng L; Chen W; Yin C; Zhang H; Zhao Q
    World Neurosurg; 2019 Jul; 127():e624-e630. PubMed ID: 30930327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine protects against lung ischemia-reperfusion injury by the PI3K/Akt/HIF-1α signaling pathway.
    Zhang W; Zhang JQ; Meng FM; Xue FS
    J Anesth; 2016 Oct; 30(5):826-33. PubMed ID: 27412350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart.
    Ibacache M; Sanchez G; Pedrozo Z; Galvez F; Humeres C; Echevarria G; Duaso J; Hassi M; Garcia L; Díaz-Araya G; Lavandero S
    Biochim Biophys Acta; 2012 Apr; 1822(4):537-45. PubMed ID: 22230708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of dexmedetomidine on amino acid contents and the cerebral ultrastructure of rats with cerebral ischemia-reperfusion injury.
    Lin S; Zhou G; Shao W; Fu Z
    Acta Cir Bras; 2017 Jun; 32(6):459-466. PubMed ID: 28700007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of ginsenosides on serous metabonomic profiles in cerebral ischemia-reperfusion rats based on ~1H-NMR].
    Cao DM; Guan QX; Liu YL; Wang SM
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1142-1148. PubMed ID: 32237458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine attenuates cerebral ischemia-reperfusion injury in rats by inhibiting the JNK pathway.
    Zhao B; Li D; Zhang S; He L; Ai Y
    Ann Palliat Med; 2021 Jun; 10(6):6768-6778. PubMed ID: 34237977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.